Lisa Ferguson
Nurse Practitioner · Terre Haute, INNPI 1548669831
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,690 of the $11,110 with a category attached, or 69.2%. 36 manufacturers reported payments, led by Boston Scientific at 28.2% of the total. Among nurse practitioner clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 272 payments — averaging $40.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Edwards Lifesciences$2K
- Novo Nordisk$790
- GSK$737
- AbbVie$696
- AstraZeneca$613
- plus $3K from 30 others
What the payments were for
- Travel & lodging$3,28630%
- Food & beverage$7,69069%
- Education$1341%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Watchman$1,394
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,118
- WATCHMAN Access System$889
- FARXIGA$360
- Kerendia$238
- WATCHMAN FLX$130
- AREXVY$125
- VOQUEZNA$125
- RYBELSUS$123
- Saxenda$123
- MOUNJARO$123
- Repatha$123
- Veozah$123
- SHINGRIX$123
- XARELTO$123
- Wegovy$122
- MitraClip$116
- Ozempic$101
- TRELEGY ELLIPTA$100
How this compares
$11,110 in reported general payments places this provider in the 95th percentile of 2,724 nurse practitioner providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 69 | $86,913 |
| FarxigaDapagliflozin Propanediol | 80 | $67,209 |
| OzempicSemaglutide | 29 | $38,167 |
| JardianceEmpagliflozin | 25 | $27,865 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $24,568 |
| VascepaIcosapent Ethyl | 35 | $22,592 |
| TrulicityDulaglutide | 15 | $20,396 |
| Repatha SyringeEvolocumab | 21 | $20,141 |
| TradjentaLinagliptin | 18 | $17,209 |
| LinzessLinaclotide | 14 | $14,943 |
| Praluent PenAlirocumab | 11 | $9,516 |
| Repatha SureclickEvolocumab | 11 | $9,476 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $7,446 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 24 | $6,678 |
| Atorvastatin Calcium | 401 | $3,185 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $388 | $107,30984 claims |
| AstraZenecaFarxiga | $613 | $67,20980 claims |
| Boehringer IngelheimJardiance, Tradjenta | $170 | $45,07443 claims |
| Novo NordiskOzempic | $790 | $38,16729 claims |
| GSKTrelegy Ellipta, Shingrix | $737 | $27,60339 claims |
| AbbVieLinzess, Synthroid | $696 | $16,87444 claims |
| PfizerAbrysvo | $123 | $6,67824 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $33 | $2,408288 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,724 nurse practitioner providers in Indiana.
Other nurse practitioner in Terre Haute
- Lindsay GambleTerre Haute$13K
- Kindra ShepardTerre Haute$12K
- Ashley McCammonTerre Haute$9K
- Kristi OrbaughIndianapolis$1.3M
- Kimberly EadsPlainfield$302K
- Sean GoddardFort Wayne$180K
- Kacy RogersIndianapolis$77K
- Kristine TaylorFort Wayne$69K
- Brittany SavageIndianapolis$51K
- Monica HaugerTrafalgar$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.